EUPRAXIA PHARMACEUTICALS INC. Quarterly Assets in USD from Q4 2022 to Q4 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Eupraxia Pharmaceuticals Inc. quarterly Assets history and growth rate from Q4 2022 to Q4 2023.
Eupraxia Pharmaceuticals Inc. Assets for the quarter ending December 31, 2023 was $20.3M, a 5.98% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$20.3M	+$1.14M	+5.98%	Dec 31, 2023	40-F	2024-04-01
Q4 2022	$19.1M			Dec 31, 2022	40-F	2024-04-01

* An asterisk sign (*) next to the value indicates that the value is likely invalid.